You are here

Treatments

People who haven't had COVID will likely catch the new XBB.1.5 variant, experts say

Fri, 2023-01-06 17:44 — mike kraft

People who haven't had COVID will likely catch XBB.1.5 – and many will get reinfected, experts say New COVID variant XBB.1.5 is very contagious, meaning everyone is at risk for infection even if you've already had COVID. Here's what that means. YahooNews

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about People who haven't had COVID will likely catch the new XBB.1.5 variant, experts say
Log in or register to post comments

CureVac says COVID vaccine produced immune response in early-stage trial

Fri, 2023-01-06 09:19 — mike kraft

CureVac says COVID vaccine produced immune response in early-stage trial Germany's CureVac AG said on Friday its second-generation COVID-19 vaccine produced virus-neutralizing antibodies against the BA.1 subvariant of Omicron, based on preliminary data from an early-stage trial. Reuters Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about CureVac says COVID vaccine produced immune response in early-stage trial
Log in or register to post comments

NIH launches pilot telehealth program to help treat COVID

Thu, 2023-01-05 20:50 — mike kraft

NIH launches pilot COVID telehealth program The U.S. National Institutes of Health (NIH) on Thursday launched a virtual program aimed at making antiviral treatments for COVID-19 available at home for those who test positive. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about NIH launches pilot telehealth program to help treat COVID
Log in or register to post comments

Florida surgeon general used ‘flawed’ science to discourage vaccinations -- university faculty peers

Thu, 2023-01-05 10:56 — mike kraft

Fla. surgeon general used ‘flawed’ vaccine science, faculty peers say Joseph A. Ladapo may have violated University of Florida research integrity rules, a faculty task force said.

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

COVID-19 vaccine for children after MIS-C deemed safe --NIH

Wed, 2023-01-04 19:28 — mike kraft

COVID-19 vaccine for children after MIS-C appears safe NIH-supported study finds no serious complications following rare immune condition. National Institutes of Health (NIH)

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about COVID-19 vaccine for children after MIS-C deemed safe --NIH
Log in or register to post comments

Misinformation issue: Public Health Agencies Try to Restore Trust as They Fight Misinformation

Wed, 2023-01-04 18:51 — mike kraft

Public Health Agencies Try to Restore Trust as They Fight Misinformation As public health departments work on improving their message, the skepticism and mistrust often reserved for covid-19 vaccines now threaten other public health priorities, including flu shots and c… khnkytjaw Kaiser Health News

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Personnel

Public Attitudes

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Misinformation issue: Public Health Agencies Try to Restore Trust as They Fight Misinformation
Log in or register to post comments

In China, vaccine hesitancy lingers even as COVID cases surge

Tue, 2023-01-03 13:40 — mike kraft

'I don't trust it:' Vaccine hesitancy lingers even as China COVID cases surge The problem is a growing headache for Beijing as it tries to persuade more people to get vaccinated in the face of a spike in infections and the prospect of more than 1.5 million deaths after the lifting of strict anti-COVID measures. David Kirton Reuters

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Public Attitudes

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about In China, vaccine hesitancy lingers even as COVID cases surge
Log in or register to post comments

COVID booster prompts good immune response, except after recent infection --study

Tue, 2023-01-03 12:50 — mike kraft

COVID booster prompts good immune response, except after recent infection CIDRAP

A study today in Clinical Infectious Diseases finds that a third COVID-19 vaccine dose triggered a robust immune response, regardless of whether recipients had been infected more than 3 months earlier, but it didn't significantly increase antibody levels in those infected less than 3 months before.

...

Country / Region Tags:

General Topic Tags:

Disease Prevention

Medical Testing

Problem, Solution, SitRep, or ?:

Read more about COVID booster prompts good immune response, except after recent infection --study
Log in or register to post comments

China, EU in dispute over China's COVID crisis, Beijing threatens countermeasures

Tue, 2023-01-03 10:07 — mike kraft

EU, Beijing heading for collision over China's COVID crisis BRUSSELS (AP) — The European Union and China on Tuesday moved closer to a political standoff over the COVID-19 crisis, with Beijing vehemently rejecting travel restrictions some EU nations have started to impose that could well be expanded in coming days. AP NEWS

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Read more about China, EU in dispute over China's COVID crisis, Beijing threatens countermeasures
Log in or register to post comments

A promising new Covid pill shows key advantages over Paxlovid in trial

Thu, 2022-12-29 22:10 — FNUOvviyaa

A promising new Covid pill shows key advantages over Paxlovid in trial A Chinese antiviral pill was found to be as effective as Paxlovid in a Phase 3 trial, and it appeared to cause fewer side effects. NBC News

...

"You have a medication that looks to be just as good as Paxlovid, but less cumbersome," said Dr. Panagis Galiatsatos, an assistant professor of medicine at Johns Hopkins Medicine in Baltimore.

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about A promising new Covid pill shows key advantages over Paxlovid in trial
Log in or register to post comments

Pages

Page loaded in 0.597 seconds.